Comparative Effectiveness of Tocilizumab Versus Tnf Inhibitors as Monotherapy or in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis After the Use of at Least One Biologic Disease-Modifying Antirheumatic Drug: Analyses from the Pan- European Tocerra Register Collaboration